{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:01:02Z","timestamp":1792735262409,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["1402-1-125-63091"],"award-info":[{"award-number":["1402-1-125-63091"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["IR.TUMS.MEDICINE.REC.1402.144"],"award-info":[{"award-number":["IR.TUMS.MEDICINE.REC.1402.144"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e36230","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:46:04Z","timestamp":1723553164000},"page":"e36230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review"],"prefix":"10.1016","volume":"10","author":[{"given":"Mahsa","family":"Ranjbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Naeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolrahman","family":"Rostamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurosh","family":"Djafarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.heliyon.2024.e36230_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib2","first-page":"18","article-title":"Systemic sclerosis: markers and targeted treatments","volume":"41","author":"Cutolo","year":"2016","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.heliyon.2024.e36230_bib3","series-title":"Scleroderma and Primary Myocardial Disease. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022","author":"Mohameden","year":"2022"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36230_bib4","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36230_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/kjm2.12505","article-title":"Pathophysiology of systemic sclerosis (scleroderma)","volume":"38","author":"Rosendahl","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36230_bib6","first-page":"135","article-title":"Nutrition in systemic sclerosis","volume":"8","author":"Recasens","year":"2012","journal-title":"Reumatol. Cl\u00ednica"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36230_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis","volume":"10","author":"Broen","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36230_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/2397198318761480","article-title":"Etiology unknown: qualitative analysis of patient attributions of causality in scleroderma","volume":"3","author":"Gholizadeh","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36230_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/1744666X.2016.1125782","article-title":"An overview of environmental risk factors in systemic sclerosis","volume":"12","author":"De Martinis","year":"2016","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36230_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00296-021-04806-6","article-title":"Progression of gastrointestinal symptoms over time in patients with systemic sclerosis","volume":"41","author":"Bering","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36230_bib11","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3390\/diagnostics11112118","article-title":"Diet in scleroderma: is there a need for intervention?","volume":"11","author":"Burlui","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.heliyon.2024.e36230_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40674-014-0005-0","article-title":"Management of gastrointestinal involvement in scleroderma","volume":"1","author":"Nagaraja","year":"2015","journal-title":"Curr Treat Options in Rheum."},{"issue":"4 Suppl 91","key":"10.1016\/j.heliyon.2024.e36230_bib13","first-page":"S190","article-title":"Disease-related malnutrition in systemic sclerosis: evidences and implications","volume":"33","author":"Codullo","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e36230_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4014\/jmb.1906.06064","article-title":"Role of probiotics in human gut microbiome-associated diseases","volume":"29","author":"Kim","year":"2019","journal-title":"J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36230_bib15","article-title":"Probiotics for induction of remission in ulcerative colitis","volume":"3","author":"Kaur","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36230_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2146\/ajhp090168","article-title":"Probiotics","volume":"67","author":"Williams","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36230_bib17","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4014\/jmb.1710.10001","article-title":"Difference in the gut microbiome between ovariectomy-induced obesity and diet-induced obesity","volume":"27","author":"Choi","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e36230_bib18","article-title":"Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Rahimlou","year":"2022","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36230_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14724","article-title":"Effect of probiotics supplementation on disease progression, depression, general health, and anthropometric measurements in relapsing\u2010remitting multiple sclerosis patients: A systematic review and meta\u2010analysis of clinical trials","volume":"75","author":"Mirashrafi","year":"2021","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12765","article-title":"Intestinal dysbiosis and probiotic applications in autoimmune diseases","volume":"152","author":"de Oliveira","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.heliyon.2024.e36230_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102507","article-title":"A systematic review and meta-analysis: the effects of probiotic supplementation on metabolic profile in patients with neurological disorders","volume":"53","author":"Tamtaji","year":"2020","journal-title":"Compl. Ther. Med."},{"key":"10.1016\/j.heliyon.2024.e36230_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fnut.2020.00157","article-title":"Benefits of probiotics in rheumatic diseases","volume":"7","author":"Oliviero","year":"2020","journal-title":"Front. Nutr."},{"key":"10.1016\/j.heliyon.2024.e36230_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.heliyon.2024.e36230_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.18203\/issn.2454-2156.IntJSciRep20161467","article-title":"Effect of probiotics in the treatment of gastrointestinal symptoms in patients with scleroderma","volume":"2","author":"Enteshari-Moghaddam","year":"2016","journal-title":"Int J Sci Rep."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36230_bib25","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/rheumatology\/kez160","article-title":"Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial","volume":"58","author":"Marighela","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.heliyon.2024.e36230_bib26","series-title":"Seminars in Arthritis and Rheumatism","article-title":"A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e36230_bib27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s10620-019-05830-0","article-title":"Effectiveness of Saccharomyces boulardii and metronidazole for small intestinal bacterial overgrowth in systemic sclerosis","volume":"65","author":"Garc\u00eda-Collinot","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36230_bib28","first-page":"S22","article-title":"Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating\/distention","volume":"29","author":"Frech","year":"2011","journal-title":"Clinical and Experimental Rheumatology-Incl Supplements"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.41933","article-title":"Systemic sclerosis\u2013associated interstitial lung disease: how to incorporate two food and drug administration\u2013approved therapies in clinical practice","volume":"74","author":"Khanna","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36230_bib30","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.3390\/jcm11123412","article-title":"Influence of probiotics in prevention and treatment of patients who undergo chemotherapy or\/and radiotherapy and suffer from mucositis, diarrhoea, constipation, nausea and vomiting","volume":"11","author":"Garczyk","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36230_bib31","first-page":"165","article-title":"Evaluation and management of esophageal manifestations in systemic sclerosis","volume":"31","author":"Denaxas","year":"2018","journal-title":"Ann. Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36230_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.14639\/0392-100X-N0477","article-title":"Upper dysphagia in patients affected by systemic sclerosis: prevalence and features","volume":"40","author":"Galli","year":"2020","journal-title":"Acta Otorhinolaryngol. Ital."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36230_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/2397198319890813","article-title":"Validity and correlates of the brief satisfaction with appearance scale for patients with limited and diffuse systemic sclerosis: analysis from the university of California, Los Angeles scleroderma quality of life study","volume":"5","author":"Fox","year":"2020","journal-title":"Journal of Scleroderma and Related Disorders"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/jsrd.5000264","article-title":"Validation of the social interaction anxiety scale in scleroderma: a scleroderma patient-centered intervention network cohort study","volume":"3","author":"Gholizadeh","year":"2018","journal-title":"Journal of Scleroderma and Related Disorders"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36230_bib35","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/S2665-9913(20)30027-8","article-title":"How can fatigue be addressed in individuals with systemic sclerosis?","volume":"2","author":"Stamm","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36230_bib36","first-page":"1630","article-title":"Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6","volume":"30","author":"Merkel","year":"2003","journal-title":"J. Rheumatol."},{"issue":"46","key":"10.1016\/j.heliyon.2024.e36230_bib37","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v22.i46.10093","article-title":"Can probiotics benefit children with autism spectrum disorders?","volume":"22","author":"Navarro","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36230_bib38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24676","article-title":"Health\u2010related quality of life in systemic sclerosis: a systematic review","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1757-4749-1-19","article-title":"Probiotics and gastrointestinal disease: successes, problems and future prospects","volume":"1","author":"Culligan","year":"2009","journal-title":"Gut Pathog."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.gastro.2010.11.010","article-title":"Probiotics, enteric and diarrheal diseases, and global health","volume":"140","author":"Preidis","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2024.e36230_bib41","series-title":"Seminars in Pediatric Surgery","article-title":"Probiotics and necrotizing enterocolitis","year":"2018"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36230_bib42","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.sjbs.2022.02.044","article-title":"Efficacy of probiotics-based interventions as therapy for inflammatory bowel disease: a recent update","volume":"29","author":"Selvamani","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e36230_bib43","article-title":"Low fodmap diet and probiotics in irritable bowel syndrome: a systematic review with network meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36230_bib44","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.4049\/jimmunol.172.2.1118","article-title":"Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody Repertoire1","volume":"172","author":"Rhee","year":"2004","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36230_bib45","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ajg.2010.218","article-title":"Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study","volume":"105","author":"Tursi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36230_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000342079","article-title":"Probiotic mechanisms of action","volume":"61","author":"Bermudez-Brito","year":"2012","journal-title":"Ann. Nutr. Metabol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36230_bib47","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.clnu.2021.02.015","article-title":"Effect of synbiotics and probiotics supplementation on autoimmune diseases: a systematic review and meta-analysis of clinical trials","volume":"40","author":"Askari","year":"2021","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.heliyon.2024.e36230_bib48","series-title":"The Autoimmune Diseases","first-page":"213","article-title":"Chapter 11 - dendritic cells in autoimmune disease","author":"Tarbell","year":"2020"},{"key":"10.1016\/j.heliyon.2024.e36230_bib49","series-title":"The Autoimmune Diseases","first-page":"17","article-title":"Chapter 3 - general features of autoimmune disease","author":"Davidson","year":"2020"},{"key":"10.1016\/j.heliyon.2024.e36230_bib50","series-title":"Interplay between Mediterranean Diet and Gut Microbiota in the Interface of Autoimmunity: an Overview","author":"Tsigalou","year":"2020"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36230_bib51","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri1373","article-title":"Interactions between commensal intestinal bacteria and the immune system","volume":"4","author":"Macpherson","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e36230_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fnut.2020.00157","article-title":"Benefits of probiotics in rheumatic diseases","volume":"7","author":"Oliviero","year":"2020","journal-title":"Front. Nutr."},{"key":"10.1016\/j.heliyon.2024.e36230_bib53","article-title":"Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: a systematic review and meta-analysis of 34 randomized controlled trials","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36230_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-018-0758-9","article-title":"Update on the gastrointestinal microbiome in systemic sclerosis","volume":"20","author":"Bellocchi","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36230_bib55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nature medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-016-0299-7","article-title":"An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis","volume":"8","author":"Chen","year":"2016","journal-title":"Genome Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36230_bib57","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/art.39785","article-title":"Suppression of inflammatory arthritis by human gut\u2010derived Prevotella histicola in humanized mice","volume":"68","author":"Marietta","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36230_bib58","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.39783","article-title":"Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine","volume":"68","author":"Maeda","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36230_bib59","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/annrheumdis-2018-214514","article-title":"Prevotella copri in individuals at risk for rheumatoid arthritis","volume":"78","author":"Alpizar-Rodriguez","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36230_bib60","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1136\/annrheumdis-2019-216565","article-title":"Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study","volume":"80","author":"Inamo","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36230_bib61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/jcm8050693","article-title":"Gut microbial composition and function are altered in patients with early rheumatoid arthritis","volume":"8","author":"Jeong","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2024.e36230_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703277","article-title":"Flood control: how milk-derived extracellular vesicles can help to improve the intestinal barrier function and break the gut\u2013joint axis in rheumatoid arthritis","volume":"12","author":"Aarts","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36230_bib63","article-title":"Microbiome in rheumatoid arthritis and celiac disease: a friend or foe","volume":"13","author":"Elsouri","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36230_bib65","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10620-007-0018-8","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"53","author":"Domsic","year":"2008","journal-title":"Dig. Dis. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e36230_bib66","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36230_bib67","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.39572","article-title":"Association of systemic sclerosis with a unique colonic microbial consortium","volume":"68","author":"Volkmann","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000134","article-title":"Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts","volume":"4","author":"Volkmann","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","article-title":"Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease","volume":"18","author":"Andr\u00e9asson","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14889-6","article-title":"Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement","volume":"7","author":"Patrone","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1572-0241.2001.03353.x","article-title":"Gastric involvement in systemic sclerosis: a prospective study","volume":"96","author":"Marie","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib72","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/nu12010132","article-title":"Gastroesophageal reflux disease and probiotics: a systematic review","volume":"12","author":"Cheng","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36230_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-94-6-749","article-title":"Abnormal colonic motility in progressive systemic sclerosis","volume":"94","author":"Battle","year":"1981","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36230_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11894-019-0699-0","article-title":"Colonic and anorectal manifestations of systemic sclerosis","volume":"21","author":"Sattar","year":"2019","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36230_bib75","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.clnu.2022.10.015","article-title":"Probiotics and synbiotics in chronic constipation in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"41","author":"van der Schoot","year":"2022","journal-title":"Clinical Nutrition"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36230_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S0029665119000934","article-title":"Probiotics and constipation: mechanisms of action, evidence for effectiveness and utilisation by patients and healthcare professionals","volume":"79","author":"Dimidi","year":"2020","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.heliyon.2024.e36230_bib77","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s10620-018-4977-8","article-title":"Intestinal involvement in systemic sclerosis: a clinical review","volume":"63","author":"Sakkas","year":"2018","journal-title":"Dig. Dis. Sci."},{"issue":"6 Suppl 86","key":"10.1016\/j.heliyon.2024.e36230_bib78","first-page":"214","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36230_bib79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/2040622313496126","article-title":"Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance","volume":"4","author":"Sachdev","year":"2013","journal-title":"Therapeutic advances in chronic disease"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36230_bib80","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/rheumatology\/34.3.265","article-title":"Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome","volume":"34","author":"Kaye","year":"1995","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36230_bib81","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth","volume":"51","author":"Zhong","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36230_bib82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41424-018-0030-7","article-title":"Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis","volume":"9","author":"Rao","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36230_bib83","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1529-0131(199810)41:10<1874::AID-ART21>3.0.CO;2-T","article-title":"Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study","volume":"41","author":"Marie","year":"1998","journal-title":"Arthritis Rheum.: Official Journal of the American College of Rheumatology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36230_bib84","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2036.2006.02804.x","article-title":"Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)","volume":"23","author":"Sallam","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36230_bib85","first-page":"581","article-title":"Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues","volume":"56","author":"Richard","year":"2017","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e36230_bib86","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/2050640616688129","article-title":"Prevalence of fecal incontinence in a cohort of systemic sclerosis patients within a regional referral network","volume":"5","author":"Garros","year":"2017","journal-title":"United European Gastroenterology Journal"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e36230_bib87","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/ker153","article-title":"Internal anal sphincter atrophy in patients with systemic sclerosis","volume":"50","author":"Thoua","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.heliyon.2024.e36230_bib88","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1023\/B:DDAS.0000034569.85066.69","article-title":"Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence","volume":"49","author":"Heyt","year":"2004","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36230_bib89","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ajg.2011.399","article-title":"Fecal incontinence in systemic sclerosis is secondary to neuropathy","volume":"107","author":"Thoua","year":"2012","journal-title":"Official journal of the American College of Gastroenterology| ACG."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36230_bib90","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jamainternmed.2018.5403","article-title":"Probiotic safety\u2014no guarantees","volume":"178","author":"Cohen","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e36230_bib91","series-title":"Diet, Microbiome and Health","first-page":"131","article-title":"Safety of probiotics","author":"Zieli\u0144ska","year":"2018"},{"key":"10.1016\/j.heliyon.2024.e36230_bib92","first-page":"1","article-title":"Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series","volume":"18","author":"Costa","year":"2018","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.heliyon.2024.e36230_bib93","first-page":"62","article-title":"Infections and systemic sclerosis: an emerging challenge","volume":"27","author":"Barahona-Correa","year":"2020","journal-title":"Rev. Colomb. Reumatol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402412261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402412261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:21:27Z","timestamp":1773184887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402412261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":93,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S240584402412261X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36230","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e36230"}}